Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 045950/0128 | |
| Pages: | 8 |
| | Recorded: | 05/31/2018 | | |
| Attorney Dkt #: | A-2020-US-PCT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/28/2019
|
Application #:
|
15507669
|
Filing Dt:
|
02/28/2017
|
|
Publication #:
|
|
Pub Dt:
|
01/04/2018
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITION AND THERAPEUTIC COMBINATION COMPRISING A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR AND HMG CoA REDUCTASE INHIBITORS
|
|
|
Assignee
|
|
|
|
|
| GOOIMEER 2-35 |
| DC NARDEN, NETHERLANDS NL-1411 |
|
|
Correspondence name and address
|
| |
AMGEN INC.
|
| |
ONE AMGEN CENTER DRIVE
|
| |
PATENT OPERATIONS / 35-1-B / EDL
|
| |
THOUSAND OAKS, CA 91320-1799
|
Search Results as of:
05/11/2024 10:54 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
